Stock Spotlight Archives - Page 291 of 388

TuesdayJul 23, 2019 3:08 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Joint Development Agreement to Create Biosynthesis Platform for CBD Production, Distribution

Willow Biosciences (CSE: WLLW) recently entered a joint development agreement (“JDA”) with leading cannabinoid manufacturer Noramco Inc. to develop a yeast-based biosynthesis platform for the production and distribution of cannabidiol (“CBD”) (http://ibn.fm/8F330). An article further discussing the company reads, “The JDA is mutually exclusive and creates an enviable arrangement designed to take advantage of each company’s unique and compelling skill sets, the news release notes. The JDA requires each company to cover its own costs, retain its own intellectual property associated with its own scopes of work and share equally in the gross profits from sales of CBD produced under…

TuesdayJul 23, 2019 2:51 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Remains Ahead of the Pack with Innovative Delivery Technology

Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An article discussing the company reads, “One of the delivery challenges is the amount of CBD waste created, because the human body can only absorb a small amount of the molecules. DehydraTECH is disrupting this cycle by protecting the product during stomach transit, amplifying intestinal absorption by five to ten times over traditional methods and enabling the drug to bypass first-pass liver metabolism. Third-party lab studies…

TuesdayJul 23, 2019 2:00 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc.’s (ENDV) SofPulse Safely Reduces Pain, Swelling

Endonovo Therapeutics (OTCQB: ENDV) is a commercial-stage developer of noninvasive Electroceutical(TM) Therapeutic devices that target patient pain and inflammation while supporting wound recovery. An article discussing the company reads, “Targeting inflammatory conditions in vital organs and peripheral tissues, Endonovo’s SofPulse(R) is clinically proven to significantly speed the recovery process and reduce the need for potentially addictive pain medications, thereby improving the patient’s natural recovery experience (http://ibn.fm/qHmMQ). . . . The efficacy of SofPulse targeted pulsed electromagnetic field therapy (tPEMF), which uses targeted microcurrents to transmit gentle pulses to the tissue, is well documented and supported by peer-reviewed clinical research. Among the…

TuesdayJul 23, 2019 12:09 pm

QualityStocksNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) New Investment Platform Targets UK, European CBD Health and Wellness Sector

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently launched a new investment platform called Supreme Heights. Established in London, the platform will capitalize on opportunities within the UK and European CBD health-and-wellness space. An article discussing the company reads, “While Supreme Heights has been initiated as a separate entity, the platform has solid foundational support and will benefit from Supreme Cannabis’ regulatory, product commercialization, supply chain, marketing and capital markets expertise, as well as corporate support services (http://ibn.fm/Fsts5). Additionally, Supreme Heights will benefit from Supreme Cannabis’ experience launching premium brands and its team’s history of supporting health and…

FridayJul 19, 2019 3:44 pm

QualityStocksNewsBreaks – Hemptown USA Employs Strategic Hemp-Cultivation Methodology to Increase Yields, Lower Costs

Hemptown USA is employing technology to improve hemp cultivation by keeping production costs low and optimizing yields. An article discussing the company reads, “Hemptown employs a ‘soil to oil’ methodology that involves experienced professionals working in a few selected agricultural microclimates across Oregon’s Emerald Triangle, Kentucky and Colorado. In 2018, Hemptown harvested 110,000 pounds of full-spectrum biomass with CBD content of approximately 17% from the Oregon hemp farm. . . . In 2019, the company is scaling up operations to meet the growing market demand for affordable hemp and CBD oil. As per initial estimates, it will cultivate over one…

FridayJul 19, 2019 2:58 pm

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Aims to Establish Significant Presence in Global Hemp, CBD Market

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division. An article discussing the company’s entrance into the global hemp-CBD market reads, “TGOD estimates that the global CBD market will reach $22 billion in less than three years. TGOD will move into the global sector as the demand for high-quality hemp-CBD products in Europe grows. In 2018, TGOD acquired HemPoland, which has an expanding footprint and distributor network across Europe. This move is expected to…

FridayJul 19, 2019 2:41 pm

QualityStocksNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Swiftly Expanding Throughout the US

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a company with roots as a family-run business selling vape pens in Washington state, has transformed into an award-winning cannabis holding company with a multistate portfolio. An article discussing the company reads, “Headquartered in Washington, where it all began, the company is rapidly expanding throughout the United States, reaching first into Oregon, California and Nevada, with its products currently sold in 685 stores across six states, and plans in place to continue expansion into other states throughout the year. The company is focused on organic, bottom-up growth as it cultivates and delivers…

FridayJul 19, 2019 1:18 pm

QualityStocksNewsBreaks – INmune Bio Inc.’s (NASDAQ: INMB) Innovative Drug Candidate Targets Neuroinflammation to Treat Alzheimer’s Disease

INmune Bio (NASDAQ: INMB) is an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, such as Alzheimer’s disease (“AD”). A recent article discussing the company reads, “An association between inflammation and Alzheimer’s disease has long been established. Until present, however, this link and the way in which it could be used to offer reliable AD treatments have both been overlooked. Numerous inflammatory markers are found in AD patients, and several studies establish a link between chronic inflammation and the development of AD. . . . XPro1595 works by targeting the microglial immune…

FridayJul 19, 2019 1:03 pm

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors

Geyser Brands (TSX.V: GYSR) announced key appointments to its leadership team recently, including the addition of Dr. Bin Huang to the company’s board of directors (http://ibn.fm/ElFjT). An article discussing the company reads, “Joining the board of directors is Dr. Bin Huang, a seasoned, life-sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia. She most recently served as CEO of Emerald Health Therapeutics Inc. and has held senior-management roles in both startups and Fortune 500 corporations. Huang holds a PhD in plant cell biology from the…

Site Search

Company Search

Category: Stock Spotlight